Blockade of IL‐1 signalling in the MPSIIIA mouse model led to the prevention of the working memory deficit, hyperactivity correction and reduced glial activation, particularly astrogliosis, supporting the role of IL‐1 in the neuronopathic progression of MPSIIIA. This evidence concerns the gene IL1B and mucopolysaccharidosis type 3A.